Pemetrexed Pathway-Associated Germline Polymorphisms: A Useful Tool for Treatment Individualization?

W.A. Buikhuisen, J.A. Burgers, A.D. Vincent, J.H.M. Schellens, J.H. Beijnen, E.F. Smit, M. Joerger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E482-E483
JournalJournal of Clinical Oncology
Volume28
Issue number27
DOIs
Publication statusPublished - 2010

Cite this

Buikhuisen, W. A., Burgers, J. A., Vincent, A. D., Schellens, J. H. M., Beijnen, J. H., Smit, E. F., & Joerger, M. (2010). Pemetrexed Pathway-Associated Germline Polymorphisms: A Useful Tool for Treatment Individualization? Journal of Clinical Oncology, 28(27), E482-E483. https://doi.org/10.1200/JCO.2010.29.1559